iSonea picks manufacturing partner for AirSonea


By Dylan Bushell-Embling
Wednesday, 19 June, 2013

iSonea (ASX:ISN) has selected Hong Kong-based Refined Manufacturing to produce its AirSonea mobile wheeze monitoring device.

iSonea, which plans to launch the product in the Australian market in September, had already engaged Refined to produce several prototype AirSonea units. Refined will now scale up to prepare for commercial manufacturing.

“Finding a source with extensive experience and scalability to manufacture products that are smart-phone compatible was a crucial step in our transition to commercial production,” iSonea CEO Michael Thomas said.

AirSonea will allow patients to track and share acoustic respiratory monitoring data via smart phones.

Last week, iSonea released the results of a survey suggesting that 80% of Australian GPs surveyed would recommend AirSonea to their patients.

The company also recently unveiled AsthmaSense cloud, a cloud-based asthma monitoring tool.

iSonea shares were trading 8.11% higher at $0.40 as of around 1.30 pm on Wednesday.

Related News

Cancer drug eliminates bone metastasis in lab models

Researchers have developed a novel treatment that is specific to breast cancer bone metastasis...

TGA rejects Alzheimer's drug due to safety concerns

The TGA determined that the demonstrated efficacy of lecanemab in treating Alzheimer's did...

Defective sperm doubles pre-eclampsia risk in IVF patients

A high proportion of the father's spermatozoa possessing DNA strand breaks is associated with...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd